Kronox Lab Sciences Limited (BOM:544187)
India · Delayed Price · Currency is INR 216.05
+29.70 (15.94%)
At close: Aug 21, 2026
Kronox Lab Sciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 276.6 | 254.67 | 213.51 | 164.03 | 136.27 |
Depreciation & Amortization | 20.48 | 13.82 | 12.89 | 14.97 | 20.29 |
Loss (Gain) From Sale of Assets | -0.48 | - | - | -0.11 | -0.26 |
Loss (Gain) From Sale of Investments | - | - | -0.02 | 0.03 | -0.08 |
Other Operating Activities | -33.68 | -15.89 | -8.42 | -3.97 | 2.77 |
Change in Accounts Receivable | -12.97 | -22.42 | 9.07 | 75.32 | -103.5 |
Change in Inventory | -19.98 | 28.81 | -0.79 | -16.62 | -20.17 |
Change in Accounts Payable | -6.5 | 6.69 | -20.7 | -37.15 | 55 |
Change in Other Net Operating Assets | 15.45 | 41.29 | -31.39 | 0.16 | -0.12 |
Operating Cash Flow | 238.93 | 306.97 | 174.15 | 196.65 | 90.2 |
Operating Cash Flow Growth | -22.17% | 76.26% | -11.44% | 118.02% | -20.28% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -33.07 | -31.04 | -122.7 | -84.15 | -37.96 |
Sale of Property, Plant & Equipment | 3.14 | - | - | 0.21 | 0.81 |
Investment in Securities | -245.08 | -270.66 | -60.59 | 13.73 | -42.04 |
Other Investing Activities | 36.81 | 17.76 | 10.17 | 4.25 | 3.2 |
Investing Cash Flow | -238.2 | -283.94 | -173.12 | -65.96 | -75.99 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | 16.07 | - | - | - | 6.29 |
Net Debt Issued (Repaid) | 16.07 | - | - | - | 6.29 |
Repurchase of Common Stock | - | - | - | -125 | - |
Common Dividends Paid | -18.55 | -18.54 | - | - | - |
Other Financing Activities | -1.14 | - | - | -8.95 | -12.95 |
Financing Cash Flow | -3.62 | -18.54 | - | -133.96 | -6.66 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | -0.01 | -0 | - | - | 0.01 |
Net Cash Flow | -2.9 | 4.49 | 1.03 | -3.26 | 7.56 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 205.86 | 275.92 | 51.45 | 112.5 | 52.24 |
Free Cash Flow Growth | -25.39% | 436.31% | -54.27% | 115.36% | -45.94% |
Free Cash Flow Margin | 20.34% | 27.54% | 5.73% | 11.77% | 6.34% |
Free Cash Flow Per Share | 5.59 | 7.44 | 1.39 | 2.91 | 1.34 |
Levered Free Cash Flow | 172.09 | 241.97 | 13.3 | 76.95 | 22.91 |
Unlevered Free Cash Flow | 172.8 | 241.97 | 13.3 | 77.53 | 25.44 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 1.14 | - | - | 0.93 | 4.05 |
Cash Income Tax Paid | 97.2 | 88.83 | 73.49 | 57.22 | 47.9 |
Change in Working Capital | -24 | 54.37 | -43.81 | 21.71 | -68.79 |